Patents

Patents
Protecting groundbreaking innovations in neurodegenerative disease diagnostics.
Issued U.S. Patents
1
BIOMARKERS AND DIAGNOSTIC METHODS FOR ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS, US 9,958,460
US 9,958,460
2
BIOMARKERS AND DIAGNOSTIC METHODS FOR ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS, US 11,619,637
US 11,619,637
3
BIOMARKERS AND DIFFERENTIAL DIAGNOSIS OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS, US 10,203,342
US 10,203,342
4
QUANTIFICATION OF SUBPOPULATIONS OF EXOSOMES AND DIAGNOSIS OF NEUROGENERATIVE DISORDERS, US 11,852,635, B2
US 11,852,635, B2
Expanding Protection
Multiple patent applications and continuations pending
In addition to the issued U.S. patents, NanoSomiX has multiple patent application and continuations pending in the U.S. to cover its technology and clinical use in neurologic disorders.
Other Worldwide Patents
NanoSomiX also has additional issued patents in Israel, Japan, and Korea along with multiple pending worldwide applications covering the company's technology and its use.